Tumor necrosis factor-alpha (TNFα) acts as a major pro-inflammatory and tissue damage-promoting effector during the pathogenesis of CD; this is supported by evidence provided by studies involving experimental mouse models and the therapeutic effects of TNFα-neutralizing reagents in IBD treatment [11,12,13]. Here, TNF is linked to inflammatory bowel disease.